🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

10+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 10 of 10 recruiting trials for “Carcinoma of the ampulla of Vater

Phase 2RecruitingNCT07282912

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

👨‍⚕️ Kiran Turaga, MD, Yale University📍 1 site📅 Started Mar 2026View details ↗
Phase 3RecruitingNCT07081360

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

👨‍⚕️ Saleh K Saleh, MD, Minia University📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT06801899

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

👨‍⚕️ Anna S Wenning, MD, PhD, Department of Visceral Surgery and Medicine Inselspital, Bern University Hospital📍 7 sites📅 Started May 2025View details ↗
NARecruitingNCT05780684

Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

👨‍⚕️ Gabriel A Brooks, M.D., Dartmouth-Hitchcock Medical Center📍 1 site📅 Started Jul 2023View details ↗
NAEnrolling by InvitationNCT06076252

Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma

👨‍⚕️ Liu Guohua, Affiliated Hospital of Guangdong Medical University📍 1 site📅 Started Jul 2023View details ↗
NARecruitingNCT06068023

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

👨‍⚕️ Moh'd Abu Hilal, MD, PhD, Fondazione Poliambulanza Instituto Ospedaliero📍 1 site📅 Started Jul 2023View details ↗
NARecruitingNCT05497531

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

👨‍⚕️ Nadine Abi-Jaoudeh, MD, Chao Family Comprehensive Cancer Center📍 1 site📅 Started Sep 2022View details ↗
Phase 1, PHASE2RecruitingNCT05116072

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

👨‍⚕️ François PATTOU, MD,PhD, University Hospital, Lille📍 1 site📅 Started Feb 2022View details ↗
RecruitingNCT07199127

Duodenal Polyposis Classification in FAP

👨‍⚕️ Marco Vitellaro, M.D., Fondazione IRCCS Istituto Nazionale dei Tumori, Milano📍 2 sites📅 Started Feb 2018View details ↗
RecruitingNCT04104230

Quebec Pancreas Cancer Study

👨‍⚕️ George Zogopoulos, MD, PhD, McGill University Health Centre/Research Institute of the McGill University Health Centre📍 1 site📅 Started Mar 2012View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →